Pure Global
Taiwan FDA registration cdfc712ad7c28666239a756797486970

"Jianzhen" synovial fluid supplement of neo-dimensional joints

TW: 〝健臻〞新維立關節滑液彌補物
Taiwan flagTaiwan·Risk Class 3·GENZYME BIOSURGERY, A DIVISION OF GENZYME CORPORATION·Registered Jul 22, 2004 – Jul 22, 2024Cancelled
Registration details
Analysis ID
cdfc712ad7c28666239a756797486970
Customs Code
DHA00601077002
Company information
Manufacturer
GENZYME BIOSURGERY, A DIVISION OF GENZYME CORPORATION
Manufacturer Country
United States
Authorized Representative
SANOFI TAIWAN CO., LTD.
Product details
Intended Use
TREATMENT OF PATIENTS WITH DEGENERATIVE KNEE ARTHRITIS PAIN IS LIMITED TO CONSERVATIVE NON-PHARMACOLOGICAL TREATMENTS AND WHEN GENERAL ANALGESICS SUCH AS ACETAMINOPHEN ARE INEFFECTIVE.
Product Type (Level 1)
N Orthopedics
Import Information
import
Dates and status
Registration Date
Jul 22, 2004
Expiry Date
Jul 22, 2024
Cancellation Date
Apr 28, 2021
Cancellation information
Status
Logged out
Reason
自請註銷
About this record

Access comprehensive regulatory information for "Jianzhen" synovial fluid supplement of neo-dimensional joints in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number cdfc712ad7c28666239a756797486970 and manufactured by GENZYME BIOSURGERY, A DIVISION OF GENZYME CORPORATION. The authorized representative in Taiwan is SANOFI TAIWAN CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices